Tyrosine phosphorylation and subcellular redistribution of p125 ras guanosine triphosphatase-activating protein in human neutrophils stimulated with FMLP  by Dusi, Stefano et al.
FtiBS 16862 FEBS Letters 383 (1996) 181-184 
Tyrosine phosphorylation and subcellular redistribution of p125 ras 
guanosine triphosphatase-activating protein in human neutrophils 
stimulated with FMLP 
Stefano Dusi a,*, Marta Donini a, Frans Wientjes b, Filippo Rossi a 
alnstitute of General Pathology, University of Verona, Strada le Grazie 8, 37134 Verona, Italy 
bDepartment ofMedicine, University College London, Rayne Institute, 5 University Street, London WC1E 6J J, UK 
Received 5 February 1996; revised version received 22 February 1996 
Abstract In this paper, we show that the p125 ras guanosine 
triphosphatase-activating protein (p125 GAP) is present in the 
cytosol of human neutrophils and is transiently tyrosine 
phosphorylated and transiocated to the membranes upon cell 
activation with formyl-methionyl-leucyl-phenylalanine (FMLP). 
When concanavalin A (ConA) or phorbol 12-myristate 13- 
acetate (PMA), which both induced a long-lasting respiratory 
burst, were used as stimuli, tyrosine phosphorylation and 
translocation of p125 GAP did not occur. 
I~ey words: Neutrophils; NADPH oxidase; GTPase- 
activating proteins; Tyrosine phosphorylation 
1. Introduction 
The activation of the ras-related small GTP-binding pro- 
teins (G-proteins) results from the exchange of bound GDP 
ft,r GTP [1,2]. The intrinsic GTPase activity of such G-pro- 
teins is regulated by the guanosine triphosphatase-activating 
proteins (GAPs) [3-5]. p125 GAP is a cytosolic polypeptide 
that catalyzes the GTPase activity of p21 ras [6,7]. In growth 
ft~ctor-stimulated and tyrosine kinase-transformed rat fibro- 
basts, p125 GAP becomes tyrosine phosphorylated and is 
t~anslocated from the cytosol to cell membranes, where it in- 
teracts with its biological target, p21 ras, as well as with acti- 
wlted growth factor receptors [8-18]. It has been reported that 
p21 ras is responsible for the activation of mitogen-activated 
protein (MAP) kinases cascade [19], and that MAP kinases are 
fiwolved in the mechanisms of activation of NADPH oxidase 
[20-22], the enzymatic system responsible for the generation of 
reactive oxygen metabolites [23-30]. For this reason we inves- 
tigated whether p125 GAP is expressed by neutrophils and the 
effects of different agonists of NADPH oxidase on its subcel- 
htlar localization and tyrosine phosphorylation. 
2 Materials and methods 
2 1. Reagents 
PY20 anti-phosphotyrosine waspurchased from Transduction La- 
boratories, Lexington, Kentucky, USA; anti-human p125 GAP 
n onoclonal antibody, anti-p125 GAP rabbit polyclonal antibody, 
aad IgG2bk anti-phosphotyrosine mouse monoclonal antibody from 
hvbridoma 4G10, were from UBI, Lake Placid, NY, USA. 
2 2. Neutrophil preparation and metabolic studies 
Human neutrophils were prepared and oxygen consumption was 
measured as previously reported [31]. 
*Corresponding author. Fax: (39) (45) 8098127. 
2.3. Neutrophil activation and fractionation 
Neutrophils (3X 107/ml) were activated and fractionated as pre- 
viously reported [22,31]. 
2.4. Electrophoresis and immunoblotting 
Aliquots of samples from resting and activated neutrophil cytosol 
(35 ~tg) and membranes (50 Ixg) were subjected to SDS/PAGE on 10% 
gels, according to Laemmli [32]. Proteins were electroblotted as pre- 
viously described [22,33]. The blots were incubated overnight with 
2 ~tg/ml anti-phosphotyrosine mAbs 4G10 or 2 Ixg/ml anti-125 GAP 
polyclonal antibody in blocking buffer [31]. All the subsequent s eps 
have been performed as in [31]. When required, blots were stripped as 
previously described [33]. 
2.5. Immunoprecipitation 
For immunoprecipitation experiments, cytosol and membranes 
(3 x 107 cell equivalent) were incubated for 30 min on ice with solu- 
bilization buffer [22] and then centrifuged at 15000×g for 10 min. 
The supernatants were incubated with 4 ~tg of anti-phosphotyrosine 
PY20 or anti-125 GAP monoclonal ntibody conjugated to trisacryl- 
protein A (Pierce). All the subsequent s eps were performed as de- 
scribed in [22]. 
3. Results 
3,1. Subcellular localization of p125 GAP in human neutrophils 
Cytosolic and membrane fractions from resting and acti- 
vated neutrophils were subjected to SDS/PAGE and immuno- 
blotting with specific anti-p125 GAP polyclonal antibody. Fig. 
1 shows that this antibody recognized a 125 kDa band in the 
cytosol but not in membranes of resting neutrophils. Upon 
neutrophil stimulation with FMLP, p125 GAP translocated 
from the cytosol to the membranes (Fig. 1). This translocation 
took place as early as 20 s after FMLP stimulation, being 
maximal at 1 min. After this time, the 125 kDa band de- 
creased, disappearing from the membranes after 5-10 min. 
Fig. 1 also shows that the FMLP-induced respiratory burst 
paralleled the association of p125 GAP to the membranes. 
The subcellular localization of p125 GAP as well as the 
kinetics of its translocation, were confirmed by immunopreci- 
pitation experiments performed with an anti-125 GAP mono- 
clonal antibody (Fig. 2). 
3.2. Tyrosine phosphorylation ofp125 GAP in human 
neutrophils 
To investigate whether p125 GAP is tyrosine phosphory- 
lated in human neutrophils, cytosol and membrane fractions 
from resting and FMLP-stimulated cells used in the experi- 
ments reported in Figs. 1 and 2 were immunoprecipitated with 
anti-phosphotyrosine monoclonal antibody (PY20). Fig. 3 il- 
lustrates that PY20 immunoprecipitated p125 GAP from cy- 
tosol and membranes of FMLP-stimulated, but not resting 
neutrophils. The time course of tyrosine phosphorylation of
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Fig. 1. Kinetics of p125 GAP translocation to the membranes of human neutrophils. Neutrophils (2× 107/ml) were incubated at 37°C under 
agitation with FMLP (1 txM), ConA (300 ~tg/ml), PMA (100 ng/ml) or the solvent alone plus cytochalasin B (R); the reactions were stopped at 
the indicated times and the cells were fractionated as described under Methods. The membrane and cytosol fractions were subjected to SDS/ 
PAGE on a 10% gel, and immunoblotted with anti-p125 GAP polyclonal antibody. Values for oxygen consumption, which were determined in
parallel assays, are also reported (numbers indicate the time points at which protein translocations were investigated). Abbreviations; R, resting 
neutrophils. The data are from one experiment representative of six. 
p125 GAP (Fig. 3) paralleled the kinetics of the translocation 
of this protein (Figs. 1 and 2). 
3.3. Effect of PMA and ConA on translocation and tyrosine 
phosphorylation of p125 GAP 
To understand whether the translocation of p125 GAP is 
involved in the activation of NADPH oxidase, we investigated 
the effect of various NADPH oxidase agonists on the subcel- 
lular localization of this protein. Fig. 1 shows that p125 GAP 
was not detected by specific antibodies in membranes from 
PMA- or ConA-stimulated neutrophils. These findings were 
confirmed by experiments of immunoprecipitation f this pro- 
tein (Fig. 2). Fig. 3 shows that PMA and ConA did not in- 
duce any tyrosine phosphorylation of p125 GAP both in cy- 
tosol and membrane fractions. However, upon cell 
stimulation with PMA, the respiratory burst started at 20 s, 
reached a maximum between 1 and 2 min and then was linear 
up to 10 rain. In the case of ConA the oxygen consumption 
started at 20 s, reached a maximum at 2 min, and then re- 
mained linear up to 10 min (Fig. 1). 
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Fig. 2. Immunoprecipitation f p125 GAP from cytosol and membranes of human neutrophils. Neutrophils were stimulated and fractionated 
as described in Fig. 1. Cytosol and membrane fractions were extracted in solubilization buffer (see section 2) and immunoprecipitated with 
anti-p125 GAP monoclonal antibody. The immunoprecipitated material was subjected to SDS/PAGE on a 10% gel and immunoblotted with 
anti-p125 GAP polyclonal antibody. Immunoglobulin molecules are indicated by a dot. Abbreviations; R, resting neutrophils. The data are 
from one experiment representative of five. 
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F g. 3. Time course of tyrosine phosphorylation f p125 GAP in neutrophils. Neutrophils were stimulated and fractionated as described in Fig. 
1 Cytosol and membrane fractions were extracted in solubilization buffer and immunoprecipitated with anti-phosphotyrosine PY20 monoclonal 
a~tibody. The immunoprecipitated proteins were subjected to SDS/PAGE on a 10% gel and immunoblotted with anti-p125 GAP antibody. The 
d, ,ts indicate the position of the immunoglobulin molecules. Abbreviations; R, resting neutrophils. The data are from one experiment represen- 
ts, rive of five. 
4, Discussion 
In this paper we report for the first time that p125 GAP is 
p'esent in the cytosol of human neutrophils, and that upon 
n~utrophil stimulation with FMLP, its transient translocation 
t ,  the membrane correlates with its tyrosine phosphorylation. 
11 is possible that this phosphorylation can mediate the bind- 
ir;g of p125 GAP to the membrane, and its dephosphorylation 
is responsible for the release from the membrane. Alterna- 
ti ./ely, the tyrosine phosphorylation f p125 GAP might serve 
t, regulate its interaction with other proteins, such as 
p 90rhoGAP [11,13,14]. Attempts to coimmunoprecipitate 
p 25 GAP together with pl90rhoGAP have not been success- 
i l l .  
It is worth noting that the kinetics of translocation of p125 
(AP  paralleled that of oxygen consumption in response to 
F MLP. This observation might suggest hat p125 GAP plays 
a role in the activation of NADPH oxidase. This role is also 
sttggested by the previous finding that p125 GAP regulates the 
a,:tivity of p21 ras [6,7], which activates mitogen-activated 
wotein kinases [19]. Evidence was presented that mitogen-ac- 
ti/ated protein kinases could be involved in the activation of 
tl~e respiratory burst by FMLP [20-22]. However, the finding 
t}at the activation of the respiratory burst by PMA or ConA 
is not accompanied by tyrosine phosphorylation a d translo- 
c;Ltion of p125 GAP and the previous reports that the in vitro 
r, constitution of active NADPH oxidase does not require 
p ~25 GAP [34,35] are in contrast with this hypothesis. There- 
fire, the role of p125 GAP in the mechanisms of NADPH 
o ddase activation remains to be clarified. 
In previous studies it has been shown that p21 ras is acti- 
wtted by different stimuli, including phorbol esters [36]. Inter- 
e, tingly, the data presented in this paper show that at least in 
n ;utrophils, the ras regulator p125 GAP is affected only by 
F MLP, whose receptors act through trimeric GTP-binding 
poteins. In fact FMLP induced the tyrosine phosphorylation 
a~d translocation of p125 GAP. In contrast, PMA and ConA, 
hich activate transmembrane signalling bypassing the GTP- 
b nding proteins [23], were unable to induce the tyrosine phos- 
p lorylation and translocation of p125 GAP. This finding sug- 
g~:sts that in neutrophils p125 GAP may be a target of signals 
arising exclusively from trimeric GTP-binding proteins. 
In conclusion, our findings might indicate that, in human 
neutrophils, tyrosine phosphorylation and translocation of 
p125 GAP are related to signalling pathways selectively 
triggered by FMLP and resulting in the activation of 
NADPH oxidase and/or other functions activated by this ago- 
nist. 
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